Aayush Wellness surges 11.6% on a new product launch, capturing trader attention this morning. Meanwhile, regulatory scrutiny weighs on Aurobindo Pharma and Cipla following US FDA observations, while Advait Energy rallies 4.0% on a fresh order win. Here's what's moving.

Aurobindo Pharma

• Regulatory: US FDA completed inspections at Apitoria Unit-VI, Lannett Company LLC, and Auropeptides Ltd, noting three, four, and one compliance observations respectively. Stock closed at ₹1645.30 in the previous session, up 0.51%.
• Corporate action: AGM approved an interim dividend of ₹4 per share for FY26 with 99.99% support, though K. Nithyananda Reddy’s reappointment faced 5.87% dissent.

Avanti Feeds

• Earnings: Q1FY27 net profit fell 37.4% to ₹1,163 crore as fish meal and soya bean meal costs surged, narrowing PBT margins to 5.3%. Stock closed at ₹826.75 in the previous session, down 2.10%.
• Guidance: Targets 5.85 lakh MT feed sales and ₹175 crore capex in pet food for FY27.

Advait Energy Transitions

• Order Book: Secured a ₹134.62 crore turnkey order from MPPTCL for an Emergency Restoration System, guiding for a year-end order book of ₹1,600–1,650 crore. Stock closed at ₹2200.50 in the previous session, up 4.06%.
• Expansion: Dholera Gigafactory Phase 1 operations are scheduled to begin in Q4FY27.

Dr. Agarwal's Health Care

• Earnings: FY26 PAT surged 52.4% to ₹168 crore on strong same-store sales growth of 14.1%, with network expanding to 288 facilities. Stock closed at ₹507.80 in the previous session, up 2.25%.
• Strategy: Plans aggressive expansion in Delhi NCR over the next 2–3 years to consolidate market leadership.

Aptech

• Earnings: Q1FY27 net profit jumped 330% QoQ to ₹7.65 crore, driven by a 38% YoY rise in institutional segment revenue. Stock closed at ₹91.52 in the previous session, up 1.37%.
• Order Book: Won a ₹7.23 crore contract for computer-based exams, adding to an ₹85.10 crore disclosed order book.

Clean Max Enviro Energy Solutions

• Deal: RMC approved a ₹155 crore term sheet with Envision Energy for 1,550 MW wind turbine generators, representing ~24% of average quarterly revenue. Stock closed at ₹1250.90 in the previous session, down 1.86%.
• Corporate action: Seeks shareholder approval for related party transactions exceeding ₹10,000 crore for group renewable projects.

Ola Electric Mobility

• Product launch: Opened bookings for S1Z scooter at ₹79,999 with 301 km range, featuring indigenous Bharat Cell LFP technology. Stock closed at ₹38.98 in the previous session, up 3.59%.
• Incentive: Secured ₹95.81 crore under PLI-Auto Scheme for FY27, marking third consecutive year of government support.

Protean e-Gov Technologies

• Guidance: Outlined FY27 expansion roadmap targeting DPI 2.0, enterprise digital ecosystems, and global markets. Stock closed at ₹539.75 in the previous session, down 1.31%.
• Corporate action: AGM on September 22 to approve final dividend of ₹10 per share for FY26.

Cipla

• Regulatory: USFDA classified InvaGen Unit 3 inspection as Voluntary Action Indicated (VAI), but issued Form 483 with seven observations at Pithampur plant. Stock closed at ₹1423.50 in the previous session, up 0.25%.
• Deal: JV Aspergen Ltd acquired 100% stake in Aspergen Inc., USA to rationalize group structure.

Tata Chemicals

• Deal: Acquired North American soda ash contracts from Searles Valley Minerals for $21.16 million, covering 500,000 MT through December 2028. Stock closed at ₹655.75 in the previous session, up 1.80%.

Max Estates

• Deal: Co-acquired 84.71-acre land bank in Delhi for ₹420 crore via equity swap, targeting ₹10,000–12,000 crore gross development value. Stock closed at ₹539.05 in the previous session, down 3.47%.
• Corporate action: Board meeting scheduled to consider preferential equity issue.

Ashoka Buildcon

• Order Book: Secured ₹602.16 crore order from Rail Vikas Nigam for electro-mechanical systems installation. Stock closed at ₹112.65 in the previous session, down 0.35%.

Zee Entertainment

• Corporate action: SAT granted one-day extension for warrant issuance; 44th AGM scheduled for September 17 to approve ₹2 dividend. Stock closed at ₹101.51 in the previous session, down 2.38%.
• Strategy: Eyes growth in sports, animation, and gaming segments beyond traditional broadcasting.

Aayush Wellness

• Product launch: Launched Lung Care Tablets targeting smokers, entering a ₹18,913 crore respiratory healthcare market. Stock closed at ₹27.40 in the previous session, up 11.65%.

Transformers & Rectifiers

• Order Book: Secured large transformer order worth ₹100–500 crore from Megh Engineering. Stock closed at ₹303.45 in the previous session, down 0.23%.
• Corporate action: Seeks approval to reallocate ₹5,000 million QIP proceeds for backward integration capex.

Bottom Line

Regulatory outcomes dominated pharma stocks today, with Aurobindo and Cipla facing mixed FDA signals that could impact near-term sentiment. Elsewhere, order wins in infrastructure and energy sectors provided counterweight, while consumer plays like Aayush Wellness saw sharp moves on product launches.